Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

201 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Bone marrow mesenchymal cells: biological properties and clinical applications.
Dominici M, Hofmann TJ, Horwitz EM. Dominici M, et al. J Biol Regul Homeost Agents. 2001 Jan-Mar;15(1):28-37. J Biol Regul Homeost Agents. 2001. PMID: 11388742 Review. No abstract available.
Comparison of single and dual platform methodologies for the estimation of CD34+ hematopoietic progenitor cells: correlation with colony assay.
Moretti S, Dabusti M, Castagnari B, Tieghi A, Ferrari L, Campioni D, Punturieri M, Dominici M, Castoldi GL, Lanza F. Moretti S, et al. Int J Biol Markers. 2002 Oct-Dec;17(4):259-67. doi: 10.5301/jbm.2008.5044. Int J Biol Markers. 2002. PMID: 12521130
On the development of cell therapy for genetic disorders.
Horwitz EM, Hofmann TJ, Garlits JE, Campioni D, Dominici M. Horwitz EM, et al. Cytotherapy. 2002;4(6):511-2. doi: 10.1080/146532402761624656. Cytotherapy. 2002. PMID: 12568985 Review. No abstract available.
Functional and immunophenotypic characteristics of isolated CD105(+) and fibroblast(+) stromal cells from AML: implications for their plasticity along endothelial lineage.
Campioni D, Lanza F, Moretti S, Dominici M, Punturieri M, Pauli S, Hofmann T, Horwitz E, Castoldi GL. Campioni D, et al. Cytotherapy. 2003;5(1):66-79. doi: 10.1080/14653240310000092. Cytotherapy. 2003. PMID: 12745588
Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement.
Horwitz EM, Le Blanc K, Dominici M, Mueller I, Slaper-Cortenbach I, Marini FC, Deans RJ, Krause DS, Keating A; International Society for Cellular Therapy. Horwitz EM, et al. Cytotherapy. 2005;7(5):393-5. doi: 10.1080/14653240500319234. Cytotherapy. 2005. PMID: 16236628
Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement.
Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop Dj, Horwitz E. Dominici M, et al. Cytotherapy. 2006;8(4):315-7. doi: 10.1080/14653240600855905. Cytotherapy. 2006. PMID: 16923606
Animal serum-free culture conditions for isolation and expansion of multipotent mesenchymal stromal cells from human BM.
Müller I, Kordowich S, Holzwarth C, Spano C, Isensee G, Staiber A, Viebahn S, Gieseke F, Langer H, Gawaz MP, Horwitz EM, Conte P, Handgretinger R, Dominici M. Müller I, et al. Cytotherapy. 2006;8(5):437-44. doi: 10.1080/14653240600920782. Cytotherapy. 2006. PMID: 17050248
Human bone marrow mesenchymal stromal cells express the neural ganglioside GD2: a novel surface marker for the identification of MSCs.
Martinez C, Hofmann TJ, Marino R, Dominici M, Horwitz EM. Martinez C, et al. Blood. 2007 May 15;109(10):4245-8. doi: 10.1182/blood-2006-08-039347. Epub 2007 Jan 30. Blood. 2007. PMID: 17264296 Free PMC article.
Application of multipotent mesenchymal stromal cells in pediatric patients following allogeneic stem cell transplantation.
Müller I, Kordowich S, Holzwarth C, Isensee G, Lang P, Neunhoeffer F, Dominici M, Greil J, Handgretinger R. Müller I, et al. Blood Cells Mol Dis. 2008 Jan-Feb;40(1):25-32. doi: 10.1016/j.bcmd.2007.06.021. Epub 2007 Sep 14. Blood Cells Mol Dis. 2008. PMID: 17869550 Clinical Trial.
201 results
Jump to page
Feedback